Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.


BWXT Awarded $28 Million Contract for Continued Mobile Microreactor Design

25 March 2021

(LYNCHBURG, Va. – March 25, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a $28 million, 12-month contract award from the Department of Defense’s (DoD) Strategic Capabilities Office (SCO) for the final design of a transportable microreactor prototype under the second phase of its Project Pele initiative.

BWXT Renames Laker Energy Products to BWXT Precision Manufacturing

16 March 2021

(OAKVILLE, ON – March 16, 2021) – BWXT Canada Ltd. announced today that it has renamed its subsidiary Laker Energy Products Ltd. to BWXT Precision Manufacturing Inc.

BWXT Names Jim J. Bittner Vice President and General Manager of Lynchburg, Virginia operations

15 March 2021

(LYNCHBURG, Va. – March 15, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that Jim J. Bittner has been named Vice President and General Manager of the BWXT Nuclear Operations Group, Inc. (BWXT NOG) manufacturing facility in Lynchburg, Virginia.

BWXT Awarded $35 Million in Uranium Processing and Research Reactor Fuel Contracts

11 March 2021

(LYNCHBURG, Va. – March 11, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Nuclear Operations Group, Inc. (BWXT NOG) subsidiary has been awarded a total of $35 million in contracts under two separate programs – uranium recovery and conversion as well as construction of a new research reactor fuel line.

BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region

08 March 2021

(LYNCHBURG, Va. – March 8, 2021) – BWXT Medical Ltd. (BWXT Medical) and Global Medical Solutions, Ltd. (GMS) have entered into a joint venture (JV) to manufacture and distribute radioisotopes and radiopharmaceuticals in the Asia-Pacific (Asia).

BWXT Subsidiary Awarded $57.5 Million Contract to Prepare for Uranium Conversion and Purification Services

01 March 2021

(LYNCHBURG, Va. – March 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its Nuclear Fuel Services, Inc. (NFS) subsidiary has received a $57.5 million contract from the National Nuclear Security Administration (NNSA) to prepare for future highly enriched uranium (HEU) conversion and purification services.

Press Contacts:

BWX Technologies, Inc.

Jud Simmons 
+1 434.522.3800

BWXT Canada Ltd.
BWXT Nuclear Energy Canada Inc.
BWXT Medical Ltd.

Monifa Miller
+1 519.242.8071

Nuclear Fuel Services, Inc.

Laura Bailey 
+1 423.743.9141